Author Archives: Megan Thomas

#In Conversation Series

Exclusive expert insights into clinical trials

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this latest episode, DDW’s Megan Thomas is in conversation with two experts… Read More

#Podcasts

#Autoimmune disease #Cancer research #Clinical trial #Fibrosis #Immunotherapy #Oncology

First-line clinical trial marks a turning point in drug development 

Genoscience Pharma, a clinical-stage biotech company developing lysosomotropic drug candidates for the treatment of cancer, fibrosis and auto-immune diseases through autophagy modulation has launched the ABE-LIVER study, along with trial sponsor Grenoble University Hospital.  The trial   This Phase IIb clinical trial will focus on first-line… Read More

#Cancer Research #News

#Biobanking #Biotechnology #Research

UK biobank offers regenerative medicine research potential  

BioGrad, a company offering medical and scientific support for education and research organisations, is to open the UK's second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park.  In collaboration with the University of Leicester, BioGrad biobank has already welcomed… Read More

#Business & Investment #News

#Collaboration #Drug development #Drug discovery #Mergers and acquisitions #Partnership

Catch up with the latest DDW Highlights episode

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Once again, research partnerships and licence agreements have dominated the news… Read More

#News

#DDW Highlights podcast

DDW Highlights: 16 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Once again, research partnerships and licence agreements have dominated the news… Read More

#Podcasts

Year change from 2022 to 2023
#Clinical trial #Clinical trial design #Covid-19 #Drug delivery #Drug development #Healthcare

Drug discovery predictions: Analysis and insight 

In January 2022, DDW’s Megan Thomas spoke to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector. As we head into 2023, DDW will be publishing a series of reflections on these predictions. Here, Thomas reflects specifically on Anita Cooper’s prediction relating to… Read More

#Exclusive Content #Opinion #Trends & Analysis

The promise and growth of cell and gene therapies

Listen to this article on the DDW Podcast: The Winter 2022/2023 issue of the Drug Discovery World Magazine is accompanied by an exclusive guide on cell and gene therapy (CGT). DDW Multimedia Editor Megan Thomas comments.  Putting this guide on cell and gene therapy (CGT) together has not only been an exercise in realising the… Read More

#Exclusive Content #Opinion

#Cancer immunotherapy #Cancer research #Covid-19 #Drug development #Drug discovery #Immunology / Virology & Vaccines #Immunotherapy #Monoclonal antibodies

Listen to the first DDW Highlights podcast for 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The drug discovery industry has hit the ground running in 2023 with… Read More

#News

#DDW Highlights podcast

DDW Highlights: 9 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The drug discovery industry has hit the ground running in 2023 with… Read More

#Podcasts

#DDW Highlights podcast #In Conversation Series #Narrated podcasts #Sitting Down With

The DDW Podcast: 2022 in review 

As 2022 draws to a close, DDW’s Multimedia Editor and podcast host Megan Thomas rounds up all the free episodes of the DDW podcast that were released. 2022 saw the introduction of the DDW Highlights podcast as well as the In Conversation With podcast, and saw the continued success of… Read More

#Exclusive Content #News

Acute myeloid leukaemia
#Acute Myeloid Leukaemia #Biopharmaceuticals #Clinical trials #Drug development

Initially positive findings from AML treatment study 

A study by Ellipses Pharma, a global drug development company focused on accelerating the development of new oncology treatments, has presented preliminary data from the first in human Phase I/II trial of EP0042, a dual FLT-3 an Aurora kinase inhibitor, in patients with acute myeloid leukaemia (AML). … Read More

#News

#Diversity #Life science #Pistoia Alliance

Pistoia Alliance tackles lack of diversity in pharma  

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has expanded its popular Women in STEM Leadership Programme to include other underrepresented communities in a new 2023 initiative.   The three-month programme brings together leaders from life science… Read More

#News

#Clinical trials #Covid-19 #Data #Disease surveillance #Global.health #Immunology / Virology & Vaccines

Fortifying vaccines through disease surveillance and data reporting  

Shelley McLendon, SVP of Vaccine and Infectious Diseases Program Management at ICON, attended the World Vaccine Congress Europe from 16-19 October 2022 in Barcelona, Spain. There, McLendon spoke on the topic of fortifying vaccines against future pandemics, specifically discussing: The importance of disease surveillance and reporting with regard to emerging… Read More

#Exclusive Content

#3D cell culture #Drug discovery #Ex Vivo #Genomics #High Content Screening #Life sciences #Molecular Biology #Precision medicine

Podcast: Finding the right cancer drug with high-content screening

This is the latest episode of the free DDW podcast, “Finding the right cancer drug with high-content screening”. It covers an article by the same name written for Volume 23, Issue 1 – Winter 2021/22 of DDW. In the article, Lassi Paavolainen, Principal Investigator at the Institute for Molecular… Read More

#News

#Narrated podcasts

Finding the right cancer drug with high-content screening

This is the latest episode of the free DDW podcast, “Finding the right cancer drug with high-content screening”. It covers an article by the same name written for Volume 23, Issue 1 – Winter 2021/22 of DDW. In the article, Lassi Paavolainen, Principal Investigator at the Institute for Molecular… Read More

#Podcasts

#Alzheimer's #Cancer immunotherapy #Cancer research #Dermatology #Drug development #Drug discovery #Genetics / genomics #Immunology / Virology & Vaccines #Immunotherapy #Monoclonal antibodies #mRNA

Listen now: Last episode of DDW Highlights for 2022

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The focus has been on immunotherapy and genetics this week, with exciting… Read More

#News